Key result
Diabetes impairs vascular function via oxidative stress, pointing to targeted biomarkers and therapies to reduce atherogenesis.
Why the study?
Diabetes mellitus impairs endothelial function and promotes pro-atherogenetic alterations through reduced nitric oxide bioavailability and increased oxidative stress, with unclear therapeutic implications.
Answers are grounded in this paper and cite their sources.
Diabetes mellitus impairs vascular function through endothelial dysfunction and oxidative stress, which may be targeted by various therapeutic strategies and monitored via specific biomarkers.
It is widely accepted that diabetes mellitus (DM) impairs endothelial nitric oxide synthase activity as well as enhances the production of reactive oxygen species, thus resulting in diminished nitric oxide bioavailability and the consequent pro-atherogenetic alterations. Important biomarkers of the vasculature are related to endothelial dysfunction, to inflammatory and coagulation processes, and to oxidative stress in DM. Several therapeutic strategies might exert favorable effects on the vasculature of diabetic patients, such as insulin analogues, antihypertensive agents, statins, and hypoglycemic agents, whereas in spite of the prominent role of oxidative stress in diabetes, antioxidant therapy remains controversial. The use of specific biomarkers related to vascular function could be a useful therapeutic approach in such patients.
No takes yet. Share an insight, caveat, or question.
Tousoulis et al. (2013) conducted a review in Diabetes Mellitus. Diabetes mellitus impairs vascular function through endothelial dysfunction and oxidative stress, highlighting the potential utility of specific biomarkers and therapies to mitigate atherogenesis.
Synapse has enriched 10 related papers. Consider them for comparative context: